Deciphering the vedolizumab dosing conundrum in IBD: when less is more | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Commentary

Deciphering the vedolizumab dosing conundrum in IBD: when less is more

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

	Abstract	Full	Pdf
Sep 2021	956	958	382
Oct 2021	488	484	101
Nov 2021	215	211	51
Dec 2021	183	185	41
Jan 2022	173	178	30
Feb 2022	157	157	41
Mar 2022	155	159	40
Apr 2022	234	237	59
May 2022	211	212	44
Jun 2022	183	182	19
Jul 2022	653	664	131
Aug 2022	278	284	75
Sep 2022	169	184	47
Oct 2022	138	141	47
Nov 2022	84	89	19
Dec 2022	97	102	17
Jan 2023	82	83	15
Feb 2023	102	106	25
Mar 2023	82	87	29
Apr 2023	64	68	31
May 2023	60	61	17
Jun 2023	34	36	15
Jul 2023	48	50	18
Aug 2023	35	35	9
Sep 2023	56	54	26
Oct 2023	52	53	15
Nov 2023	34	34	11
Dec 2023	67	70	19
Jan 2024	14	14	7
Feb 2024	44	46	16
Mar 2024	78	77	50
Total	5226	5301	1447